• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number CEB231410
Device Problems Collapse (1099); Patient-Device Incompatibility (2682)
Patient Problem Occlusion (1984)
Event Date 01/09/2020
Event Type  Injury  
Manufacturer Narrative
Only the year of birth was provided.Therefore (b)(6) was used.The review of the manufacturing paperwork verified that this lot met all pre-release specifications.
 
Event Description
The patient presented on (b)(6) 2019 with an abdominal aortic aneurysm that was successfully treated with gore® excluder® aaa and gore® excluder® iliac branch endoprostheses (ibe).On (b)(6) 2020, follow-up imaging showed that the left external iliac artery and the ipsilateral leg of the gore® excluder® iliac branch component (ceb) appear to be compressed and thrombosed.On (b)(6) 2020, the ceb and external iliac artery were ballooned, a thrombectomy was performed and two advanta stents were successfully implanted.The ceb and the external iliac artery were reportedly patent afterwards.It was stated that the narrow implantation zone of the ceb contributed to the event.The patient tolerated the procedure.
 
Manufacturer Narrative
Imaging evaluation: intra-operative angiogram images dated (b)(6) 2019, post-implantation cta images dated (b)(6) 2020 and intra-operative angiogram images dated (b)(6) 2020 were provided for evaluation.The evaluation showed the following: intra-operative angiogram dated (b)(6) 2019 appears to show: 10:14:13 there appears to be a non-deployed device in the left external iliac artery (lei)/left common iliac artery (lci).There appears to be an anatomic narrowing in the mid-distal lci on the pre-implant angiogram 11:21:01 post-deployment of ibe components: a narrowing in the lci still appears to be visualized in the ipsilateral limb of the ibe, near the level of the contralateral ibe gate.11:33:21 narrowing in lci still visualized on post-device deployment image.Specific diameter at the narrowed location cannot be determined with angiogram imaging.Post-implantation cta dated (b)(6) 2020 appears to show: there appears to be contrast pooling outside the implanted device in the anterior/right and posterior aneurysmal sac.There appears to be a set of lumbar arteries with contrast at these levels.There appears to be contrast in the ima.It appears to communicate with the anterior pooling in the sac.There appears to be thrombus in the contralateral limb (bridging device) that extends into the lci.The distal marker of the bridging device appears to be at the level of the ibe flow divider markers or slightly distal to this level.The lei appears to be occluded.The occlusion appears to extend to the distal left external iliac artery.The ibe ipsilateral limb, in the lci, appears to be compressed at approx.14mm distal to the ibe flow divider.Lci diameter at the level of compression appears to be 14.3mm ¿ 14.8mm.Intra-operative angiogram dated (b)(6) 2020 appears to show: 16:11:43 there appears to be lack of flow around the edges of the ibe trunk.The ipsilateral limb in the lci/lei appears to be occluded.Narrowing in ibe ipsilateral limb still observed.16:48:41 there appears to be flow in the ibe ipsilateral limb in the lci and distally in the lei.17:19:28 there appears to be possible lack of flow to the edges of the implanted ibe trunk and into the ipsilateral limb in the lci/lei.17:35:25 flow appears to be restored in the lci and lei.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9680822
MDR Text Key178122458
Report Number3013164176-2020-00013
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 02/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/06/2022
Device Catalogue NumberCEB231410
Device Lot Number20564030
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/07/2020
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
-
-